Deregulation of internal ribosome entry site-mediated p53 translation in cancer cells with defective p53 response to DNA damage

Marie Jo Halaby, Benjamin R.E. Harris, W. Keith Miskimins, Margot P Cleary, DaQing Yang

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Synthesis of the p53 tumor suppressor and its subsequent activation following DNA damage are critical for its protection against tumorigenesis. We previously discovered an internal ribosome entry site (IRES) at the 5' untranslated region of the p53 mRNA. However, the connection between IRES-mediated p53 translation and p53's tumor suppressive function is unknown. In this study, we identified two p53 IRES trans-acting factors, translational control protein 80 (TCP80), and RNA helicase A (RHA), which positively regulate p53 IRES activity. Overexpression of TCP80 and RHA also leads to increased expression and synthesis of p53. Furthermore, we discovered two breast cancer cell lines that retain wild-type p53 but exhibit defective p53 induction and synthesis following DNA damage. The levels of TCP80 and RHA are extremely low in both cell lines, and expression of both proteins is required to significantly increase the p53 IRES activity in these cells. Moreover, we found cancer cells transfected with a shRNA against TCP80 not only exhibit decreased expression of TCP80 and RHA but also display defective p53 induction and diminished ability to induce senescence following DNA damage. Therefore, our findings reveal a novel mechanism of p53 inactivation that links deregulation of IRES-mediated p53 translation with tumorigenesis.

Original languageEnglish (US)
Pages (from-to)4006-4017
Number of pages12
JournalMolecular and cellular biology
Volume35
Issue number23
DOIs
StatePublished - 2015

Fingerprint Dive into the research topics of 'Deregulation of internal ribosome entry site-mediated p53 translation in cancer cells with defective p53 response to DNA damage'. Together they form a unique fingerprint.

Cite this